Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ. Withdrawn: diuretics for heart failure. Cochrane Database Syst Rev. 2016;4:03838.
Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc. 2010;85(2):180–95.
Article PubMed PubMed Central Google Scholar
Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Simic D, Radovanovic S, Simic T. Novel Biomarkers of Heart Failure. Adv Clin Chem. 2017;79:93–152.
Article CAS PubMed Google Scholar
Sarhene M, Wang Y, Wei J, Huang Y, Li M, Li L, Acheampong E, Zhengcan Z, Xiaoyan Q, Yunsheng X, Jingyuan M, Xiumei G, Guanwei F. Biomarkers in heart failure: the past, current and future. Heart Fail Rev. 2019;24(6):867–903.
Gaggin HK, Januzzi JL Jr. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta. 2013;1832(12):2442–50.
Article CAS PubMed Google Scholar
Gupta VA, Nanda NC, Sorrell VL. Role of echocardiography in the diagnostic assessment and etiology of heart failure in older adults: opacify, quantify, and rectify. Heart Fail Clin. 2017;13(3):445–66.
Lancellotti P, Price S, Edvardsen T, Cosyns B, Neskovic AN, Dulgheru R, Flachskampf FA, Hassager C, Pasquet A, Gargani L, Galderisi M, Cardim N, Haugaa KH, Ancion A, Zamorano JL, Donal E, Bueno H, Habib G. The use of echocardiography in acute cardiovascular care: recommendations of the European association of cardiovascular imaging and the acute cardiovascular care association. Eur Heart J Cardiovasc Imaging. 2015;16(2):119–46.
Neskovic AN, Hagendorff A, Lancellotti P, Guarracino F, Varga A, Cosyns B, Flachskampf FA, Popescu BA, Gargani L, Zamorano JL, Badano LP. European Association of Cardiovascular I. Emergency echocardiography: the European Association of Cardiovascular Imaging recommendations. Eur Heart J Cardiovasc Imaging. 2013;14(1):1–11.
Dias FS, Rezende EA, Mendes CL, Silva JM Jr, Sanches JL. Hemodynamic monitoring in the intensive care unit: a Brazilian perspective. Rev Bras Ter Intensiva. 2014;26(4):360–6.
Article PubMed PubMed Central Google Scholar
Vieillard-Baron A, Slama M, Cholley B, Janvier G, Vignon P. Echocardiography in the intensive care unit: from evolution to revolution? Intensive Care Med. 2008;34(2):243–9.
Sorrell VL, Nanda NC. Role of echocardiography in the diagnostic assessment and etiology of heart failure in the elderly–opacify, quantify, and rectify. Clin Geriatr Med. 2007;23(1):31–59.
Tait L, Roalfe AK, Mant J, Cowie MR, Deeks JJ, Iles R, Barton PM, Taylor CJ, Derit M, Hobbs FD. The REFER (REFer for EchocaRdiogram) protocol: a prospective validation of a clinical decision rule, NT-proBNP, or their combination, in the diagnosis of heart failure in primary care. Rationale and design. BMC Cardiovasc Disord. 2012;30(12):97.
Chen S, Zhou Y, Wu X, Shi S, Wu H, Li P. The value of echocardiography combined with NT-pro BNP level in assessment and prognosis of diastolic heart failure. Comput Math Methods Med. 2022;2022:2102496.
PubMed PubMed Central Google Scholar
Severino P, Maestrini V, Mariani MV, Birtolo LI, Scarpati R, Mancone M, Fedele F. Structural and myocardial dysfunction in heart failure beyond ejection fraction. Heart Fail Rev. 2020;25(1):9–17.
Swiatkiewicz I, Magielski P, Kubica J. C-reactive protein as a risk marker for post-infarct heart failure over a multi-year period. Int J Mol Sci. 2021;22(6):3169.
Article CAS PubMed PubMed Central Google Scholar
van Wezenbeek J, Canada JM, Ravindra K, Carbone S, Trankle CR, Kadariya D, Buckley LF, Del Buono M, Billingsley H, Viscusi M, Wohlford GF, Arena R, Van Tassell B, Abbate A. C-reactive protein and N-terminal pro-brain natriuretic peptide levels correlate with impaired cardiorespiratory fitness in patients with heart failure across a wide range of ejection fraction. Front Cardiovasc Med. 2018;5:178.
Article PubMed PubMed Central Google Scholar
Heart Protection Study Collaborative G, Jonathan E, Derrick B, Emma L, Sarah P, John D, Jane A, Rory C. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the heart protection study. Lancet. 2011;377(9764):469–76.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–31. https://doi.org/10.1056/NEJMoa1707914.
Article CAS PubMed Google Scholar
Van Tassell BW, Abouzaki NA, OddiErdle C, Carbone S, Trankle CR, Melchior RD, Turlington JS, Thurber CJ, Christopher S, Dixon DL, Fronk DT, Thomas CS, Rose SW, Buckley LF, Dinarello CA, Biondi-Zoccai G, Abbate A. Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-control pilot study. J Cardiovasc Pharmacol. 2016;67(6):544–51.
Article PubMed PubMed Central Google Scholar
Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the reynolds risk score. JAMA. 2007;297(6):611–9.
Article CAS PubMed Google Scholar
Han R, Li K, Li L, Zhang L, Zheng H. Expression of microRNA-214 and galectin-3 in peripheral blood of patients with chronic heart failure and its clinical significance. Exp Ther Med. 2020;19(2):1322–8.
Anguita M, et al. Comments on the ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the task force of the clinical practice guidelines committee of the Spanish Society of Cardiology. Rev Esp Cardiol. 2012;65(10):874–8.
Caraballo C, Desai NR, Mulder H, Alhanti B, Wilson FP, Fiuzat M, Felker GM, Pina IL, O’Connor CM, Lindenfeld J, Januzzi JL, Cohen LS, Ahmad T. Clinical implications of the New York heart association classification. J Am Heart Assoc. 2019;8(23):e014240.
Article PubMed PubMed Central Google Scholar
Skrzypek A, Mostowik M, Szeliga M, Wilczynska-Golonka M, Debicka-Dabrowska D, Nessler J. Chronic heart failure in the elderly: still a current medical problem. Folia Med Cracov. 2018;58(4):47–56.
McCarthy CP, McCarthy KJ, McEvoy JW. Declining risk of sudden death in heart failure. N Engl J Med. 2017;377(18):1793.
Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Budi Siswanto B, Sliwa K, Filippatos G. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1(1):4–25.
Pastore MC, Mandoli GE, Aboumarie HS, Santoro C, Bandera F, D’Andrea A, Benfari G, Esposito R, Evola V, Sorrentino R, Cameli P, Valente S, Mondillo S, Galderisi M, Cameli M. Working group of echocardiography of the Italian Society of C. Basic and advanced echocardiography in advanced heart failure: an overview. Heart Fail Rev. 2020;25(6):937–48.
Article CAS PubMed Google Scholar
Kaptoge S, Seshasai SR, Gao P, Freitag DF, Butterworth AS, Borglykke A, Di Angelantonio E, Gudnason V, Rumley A, Lowe GD, Jorgensen T, Danesh J. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J. 2014;35(9):578–89.
Article CAS PubMed Google Scholar
Wagholikar KB, Fischer CM, Goodson A, Herrick CD, Rees M, Toscano E, MacRae CA, Scirica BM, Desai AS, Murphy SN. Extraction of ejection fraction from echocardiography notes for constructing a cohort of patients having heart failure with reduced ejection fraction (HFrEF). J Med Syst. 2018;42(11):209.
Article PubMed PubMed Central Google Scholar
Welsh P, Kou L, Yu C, Anand I, van Veldhuisen DJ, Maggioni AP, Desai AS, Solomon SD, Pfeffer MA, Cheng S, Gullestad L, Aukrust P, Ueland T, Swedberg K, Young JB, Kattan MW, Sattar N, McMurray JJV. Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study. Eur J Heart Fail. 2018;20(2):268–77.
Article CAS PubMed Google Scholar
Craig S, Kylintireas I, Kohler M, Nicoll D, Bratton DJ, Nunn AJ, Leeson P, Neubauer S, Stradling JR. Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial. J Clin Sleep Med. 2015;11(9):967–73.
Article PubMed PubMed Central Google Scholar
Lelakowski J, Dreher A, Majewski J, Bednarek J. Effects of catheter ablation of idiopathic ventricular ectopic beats on left ventricular function and exercise capacity. Kardiol Pol. 2009;67(8):847–55.
Dai M, Wang Y, Peng L, Liu X, Lu J, He L, Li K, Qian D, Wang R. Relationship between quantitative parameters of echocardiography and vascular endothelial function in patients with chronic heart failure and its predictive value for short-term MACE risk. J Healthc Eng. 2021;2021:1985962.
Article PubMed PubMed Central Google Scholar
Biasucci LM, Koenig W, Mair J, Mueller C, Plebani M, Lindahl B, Rifai N, Venge P, Hamm C, Giannitsis E, Huber K, Galvani M, Tubaro M, Collinson P, Alpert JS, Hasin Y, Katus H, Jaffe AS, Thygesen K. Study group on biomarkers in cardiology of the acute cardiovascular care association of the European society of C how to use C-reactive protein in acute coronary care. Eur Heart J. 2013;34(48):3687–90.
Swiatkiewicz I, Magielski P, Kubica J, Zadourian A, DeMaria AN, Taub PR. Enhanced inflammation is a marker for risk of post-infarct ventricular dysfunction and heart failure. Int J Mol Sci. 2020;21(3):807.
留言 (0)